In Sun Pharm. Indus.
v. Eli Lilly & Co. , 625 F.3d 719 (Fed. Cir. 2010) [ enhanced version available to lexis.com subscribers / unenhanced version available from lexisONE Free Case Law ],
Circuit departed from long-established law on obviousness-type double
patenting. The decision creates...
by Courtenay C. Brinckerhoff
As I wrote previously, Congressman Goodlatte (R-Va.)
released "a discussion
draft " of patent reform legislation on May 23, 2013. Although the stated
purpose of the draft legislation is to "address the ever increasing problem of
abusive patent litigation...
In re Hubbell, 709 F.3d 1140, 106 USPQ2d 1032 (Fed. Cir. 2013) (opinion by Circuit Judge O'Malley for a panel that also consisted of Circuit Judge Wallach; dissenting opinion by Circuit Judge Newman) [ an enhanced version of this opinion is available to lexis.com subscribers...
The judicially created doctrine of obviousness-type double patenting is intended to prevent a patentee from obtaining multiple separate patents for inventions that are not patentably distinct. On August 21, the Court of Appeals for the Federal Circuit decided the case of AbbVie Inc. v. The Mathilda and...